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Abstract. 
 
Cryo-electron microscopy and three-dimen-
sional, single-particle image analysis have been used to 
 
reveal the speciﬁc binding site of imperatoxin A (IpTx
 
a
 
) 
on the architecture of the calcium release channel/ryan-
odine receptor from skeletal muscle (RyR1). IpTx
 
a
 
 is a 
peptide toxin that binds with high afﬁnity to RyR1 and 
affects its functioning. The toxin was derivatized with 
biotin to enhance its detection with streptavidin. IpTx
 
a
 
 
binds to the cytoplasmic moiety of RyR1 between the 
clamp and handle domains, 11 nm away from the trans-
membrane pore. The proposed mimicry by IpTx
 
a 
 
of the 
dihydropyridine receptor (DHPR) II-III loop, thought 
to be a main physiological excitation-contraction trig-
ger, suggests that the IpTx
 
a
 
 binding location is a poten-
tial excitation-contraction signal transduction site.
Key words: ryanodine receptor • imperatoxin A • 
cryo-electron microscopy • three-dimensional recon-
struction • excitation-contraction coupling
 
T
 
HE
 
 ryanodine receptor isoform 1 (RyR1)
 
1
 
 is a large
multi-subunit transmembrane protein (four identi-
cal subunits of 565-kD and four 12-kD subunits)
that functions as the calcium release channel in the sarco-
plasmic reticulum (SR) of mammalian skeletal muscle (re-
cently reviewed by Franzini-Armstrong and Protasi, 1997).
Dihydropyridine receptors (DHPRs) are located in the tu-
bular invaginations of the plasma membrane known as
transverse (T) tubules. RyR1s and DHPRs meet at the
triad junctions, specialized myofiber regions where the T
tubules meet the terminal cisternae regions of the SR. At
these junctions the RyRs and DHPRs form two extended
rows in their respective membranes, appearing to form
complementary lattices from which the relative geometry
of the two receptors has been inferred (Block et al., 1988).
According to the currently favored mechanism of excita-
tion-contraction (E-C) coupling in skeletal muscle, a neuro-
nal voltage-induced conformational change in the DHPR,
by means of direct interaction with RyR1, switches RyR1
from a closed to an open configuration, thereby releasing
 
Ca
 
2
 
1
 
 from the SR and provoking muscular contraction
(Schneider and Chandler, 1973; Catterall, 1991; Rios and
Pizzaro, 1991).
The three-dimensional (3D) structure of RyR1 as deter-
 
mined by cryo-EM and image processing (Radermacher
et al., 1994; Serysheva et al., 1995; for review see Samsó
and Wagenknecht, 1998) reveals a large symmetric square-
prism shaped structure forming the cytoplasmic moiety
with 10 well-defined domains. The cytoplasmic peripheral
features are also known as “clamp” (domains 5–10) and
“handle” (domain 3). A smaller transmembrane region
bears the ion channel. The large cytoplasmic region, which
occupies the gap between the T tubule and SR membranes
at the triad junction, likely contains the site(s) of interac-
tion with the DHPR, but the precise location of this puta-
tive interaction on the surface of the RyR1 is unknown.
A peptide toxin, imperatoxin A (IpTx
 
a
 
; 33 amino acid
 
residues), isolated from the venom of scorpion 
 
Pandinus
imperator
 
, interacts specifically with the skeletal (RyR1)
and cardiac (RyR2) isoforms of the RyR. It reversibly en-
hances binding of ryanodine to the receptors (El-Hayek
et al., 1995b), and when added to the cytosolic side of sin-
gle receptors reconstituted in lipid bilayers, induces long-
lived subconductance states (Tripathy et al., 1998; Gurrola
et al., 1999). The binding location of IpTx
 
a
 
 on the RyR is
unknown, and since the peptide toxin presumably mimics
 
a DHPR domain that triggers RyR openings (Gurrola et al.,
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1999), identification of the binding location of IpTx
 
a
 
 may
shed light on the structural domains of RyR1 that partici-
pate in E-C coupling.
Image analysis of single particles in frozen solution as
observed in the electron microscope is a powerful method
for the structural study of large membrane-bound proteins
complexes, such as membrane receptors and channels,
which are not easily crystallized (Frank, 1996; Samsó and
Wagenknecht, 1998). One important application of these
methods is the determination of binding locations of mac-
romolecular ligands by 3D reconstruction of the protein-
ligand complexes. In the case of RyR1, the binding loca-
tions of calmodulin and the FK-506 binding protein have
been determined on the RyR1 (Wagenknecht et al., 1997).
In this study we take advantage of the high affinity be-
tween IpTx
 
a
 
 and RyR1 to localize the toxin binding site on
the RyR1 3D structure, which should reveal the location
of a switch for channel gating and thus provide insight into
the fundamental principles of action of this macromole-
cule. Furthermore, this location could also correspond to
an interaction site of an activating domain of the DHPR
with the RyR1.
 
Materials and Methods
 
Biocytin was purchased from Bachem BioScience, Inc. All other biochem-
icals were purchased from Sigma Chemical Co. Skeletal RyRs were iso-
lated from terminal cisternae vesicles from rabbit skeletal muscle as de-
scribed in Wagenknecht et al. (1997). IpTx
 
a
 
 was synthesized according to
its sequence (Zamudio et al., 1997) with or without biocytin at the NH
 
2
 
terminus. The peptides were prepared by the Wadsworth Center’s Peptide
Synthesis core facility on an automated synthesizer (model 431; Applied
Biosystems) using 9-fluoroenylmethoxycarbonyl chemistry with standard
cycles on 4-hydroxymethyl-phenoxymethylcopolystyrene, 1% divinylben-
zene resin. Composition and purity of the peptides were confirmed by
amino acid analysis (Systems Gold, model 126; Beckman Instruments)
and by electrospray mass spectroscopy (MAT TSQ 700; Finnigan).
[
 
3
 
H]Ryanodine binding assay was performed as indicated in Zamudio
et al. (1997).
 
Affinity Chromatography and Gel Electrophoresis
 
Purified RyR (10 
 
m
 
g) was diluted and incubated with biotinylated or non-
biotinylated IpTx
 
a
 
 in 100 
 
m
 
l binding buffer to yield the following final con-
centrations: 20 mM MOPS-NaOH (pH 7.4), 200 mM NaCl, 0.3% (vol/vol)
CHAPS, 0.1 mM CaCl
 
2
 
, 0.24 mM DTT, 1 mM NEM, 5 
 
m
 
g/ml leupeptin,
and 2.6 
 
m
 
M IpTx
 
a
 
. Preequilibrated streptavidin (SA)-agarose (40 
 
m
 
l of a
50% slurry) was added. The mixture was shaken for 15 min at room tem-
perature. The supernatant was recovered by centrifugation for 2 min at
1,000 
 
g
 
. The sedimented SA-agarose was resuspended in 100 
 
m
 
l washing
buffer of the following composition: 20 mM MOPS-NaOH (pH 7.4), 200 mM
NaCl, 0.3% (vol/vol) CHAPS, 0.1 mM CaCl
 
2
 
, and 5 
 
m
 
g/ml leupeptin. The
mixture was recentrifuged and the supernatant saved. This step was re-
peated nine times. Subsequently, the RyR was eluted batchwise in three
steps with 125 
 
m
 
l elution buffer that contained 0.1 M sucrose, 2% SDS,
62.5 mM Tris-HCl (pH 6.8), 2 mM EDTA, 50 mM DTT, and 0.01% (wt/
vol) bromophenol blue. All the supernatants recovered (100 
 
m
 
l each)
were also mixed with 25 
 
m
 
l fivefold concentrated elution buffer. Aliquots
(40 
 
m
 
l) were applied onto discontinuous SDS-polyacrylamide gels (3.5%
stacking and 5% resolving gel). The resolved proteins were visualized by
Coomassie staining.
 
Cryo-EM and Image Processing
 
RyR1:IpTx
 
a
 
-B:SA complexes were prepared in 20 mM Tris-HCl, pH 7.4,
0.15 M KCl, 0.1 mM CaCl
 
2
 
, and incubated between 10 and 30 min at room
temperature before cryo-grid preparation. A 20-fold molar excess of IpTx
 
a
 
and SA over RyR1 was used. Vitrified specimens were prepared on 300-
mesh carbon-coated gold grids as described in Wagenknecht et al. (1997).
Samples were examined on a Philips 420 electron microscope operated at
100 kV under low-dose conditions at a magnification of 52,000. Under-
 
focus was 1.8 
 
m
 
m. Micrographs were scanned on a Hi-Scan microdensi-
tometer (Eurocore) using a pixel size corresponding to 3.85 Å on the spec-
imen. Images were processed using the software SPIDER/WEB (Frank et
al., 1996). 3D reconstructions were obtained following the projection-
matching method (Penczek et al., 1994), taking care that all eulerian angles
in both control and experimental volumes were well represented (Boisset
et al., 1998). The total number of particles used for the final volumes was
3,900 and 2,347 particles for the IpTx
 
a
 
-containing and the control sample,
respectively, after removing oversampled views and noisy images. 3D vol-
umes were filtered to their limiting resolution, its value obtained using the
Fourier shell correlation with a cutoff value at 0.5 (see appendix in Mal-
hotra et al., 1998). The density threshold chosen for isosurface representa-
tion was the midpoint of the 3D boundary density profile.
 
Results
 
IpTx
 
a
 
-B Activity and Stability of IpTx
 
a
 
-B:SA Complex
 
IpTx
 
a
 
 was synthesized with a biocytin group added to the
NH
 
2
 
 terminus to facilitate its detection by cryo-EM using
SA. Biotin-derivatized IpTx
 
a
 
 (IpTx
 
a
 
-B) retained the ryan-
odine-binding enhancement property of the native toxin,
although higher concentrations were needed to obtain the
same half-maximal effect, and the plateau of maximal ef-
fect was 80% of that for native IpTx
 
a
 
 (Fig. 1 a). The affin-
ity of IpTx
 
a
 
-B
 
 
 
for RyR1 is within the range suitable for
cryo-EM.
Precipitation of RyR1 by SA-agarose in the presence of
IpTx
 
a
 
-B confirms that a stable complex forms between
IpTx
 
a
 
-B and RyR1 (Fig. 1 b). The SA-agarose resin does
not precipitate RyR1 when the mixture contains IpTx
 
a
 
 in-
stead of IpTx
 
a
 
-B (Fig. 1 b).
 
Cryo-EM and IpTx
 
a
 
-B:SA Difference Map
 
RyR1 was incubated with a molar excess of IpTx
 
a
 
-B and
SA, and prepared for cryo-EM in parallel with a control
reaction consisting of RyR1 and SA. In the presence of
IpTx
 
a
 
-B and SA the receptors distributed homogeneously
on the grid, but some dimers and a few higher oligomers
formed, probably due to the tetravalent binding potential
of both RyR1 for IpTx
 
a
 
-B and SA for biotin (Fig. 2 a). The
control specimen (Fig. 2 b) showed mostly individual
channels and some small particles on the background, pre-
sumably corresponding to free SA (in the experimental
sample, less free SA was observed because a significant
fraction of the SA was presumably bound by the RyR1:
IpTx
 
a
 
-B). Although these observations are indicative of
the formation of RyR1:IpTx
 
a
 
-B:SA complexes, it is impos-
sible to assert by direct visual examination of the raw mi-
crographs whether particular RyR1s contain ligand, and if
so, where it is located.
 
Two-dimensional (2D) Analysis
 
2D image processing was performed on the frequently
occurring square-shaped views of RyR1 as described in
Wagenknecht et al. (1997). Both experimental and control
2D averages display the characteristic morphology with
four protruding corners (clamps) and a central low-density
cross (Fig. 3, a and b). Careful inspection reveals an extra
mass density in the case of RyR1 incubated with SA and
IpTx
 
a
 
-B versus the RyR1 incubated with SA only (Fig. 3 a,
arrowheads). The difference map (Fig. 3 c) takes the form
of four sharp, discrete, and elongated positive densities 
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that are attributed to bound IpTx
 
a
 
-B:SA, and weaker dif-
ferences that possibly correspond to minor conformational
readjustments. The 
 
t
 
 test shows the regions of the differ-
ence map significant at the 98% confidence level (Fig. 3
d). These regions correspond to the main differences
shown in Fig. 3 c.
 
3D Analysis
 
3D reconstructions were computed for both control and
experimental samples. Surface renderings of the recon-
structed volumes filtered to their limiting resolution of 29
Å (Fig. 4) show the characteristic square-prism cytoplas-
Figure 1. (a) Dose-dependent activation of [3H]ryanodine bind-
ing by native and biotinylated IpTxa. Skeletal SR vesicles were
incubated with 7 nM [3H]ryanodine in the absence (control,
100%) and the indicated concentrations of native (open circles)
or biotinylated IpTxa (filled circles). The binding reaction was
carried out for 90 min at 368C in medium containing 0.2 M KCl,
10 mM Na-Hepes (pH 7.2), and 10 mM CaCl2. Free and bound
ligand were separated by rapid filtration, as previously described
(Gurrola et al., 1999). Data were fitted with the equation:
B 5 B0/(1 1 [ED50]/[IpTxa]); where B is the specific binding of
[3H]ryanodine (obtained by subtracting the binding in the pres-
ence of 10 mM ryanodine), B0 is the specific binding of [3H]ryano-
dine in the absence of IpTxa (0.38 6 0.06 pmol/mg protein, n 5 4),
and ED50 is the concentration of IpTxa that produces half-maxi-
mal effect (9.8 and 45 nM for native and biotinylated IpTxa, re-
spectively). (b) Precipitation of RyR1 by biotinylated IpTxa, us-
ing SA-agarose. Purified RyR was incubated with 60-fold molar
excess of biotinylated-IpTxa (IpTxa-B) or nonbiotinylated IpTxa
(IpTxa), and SA-agarose equilibrated as described in Materials
and Methods. The affinity matrix was washed 10 times (W1–
W10), and RyR was eluted using SDS and DTT (E1 and E2). Al-
iquots corresponding to the first supernatant (S), wash superna-
tants (W1–W10), and material released by denaturation (E1 and
E2) were applied onto SDS-polyacrylamide gels. Proteins were
visualized by Coomassie staining. The position of the RyR is indi-
cated.
Figure 2. Unprocessed cryo-electron micrographs. (a) RyR1 in-
cubated in the presence of IpTxa-B and SA. (b) RyR1 control in-
cubated in the presence of SA (without IpTxa-B). Arrowheads
point to typical RyR1 square-shaped views, arrows point to
RyR1 side views. Bar, 29 nm. 
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mic moiety containing 10 well-defined domains and the
smaller transmembrane assembly that have been docu-
mented previously (Radermacher et al., 1994; Serysheva
et al., 1995). A major difference between the two recon-
structions occurs in the crevice delimited by domains 3 and
7/8 of the control reconstruction, which appears to be
filled in by density in the reconstruction done in the pres-
ence of IpTx
 
a
 
-B and SA (compare Fig. 4, a and b). When
the two volumes were subtracted, and the difference vol-
ume is displayed at the same threshold as the control and
experimental volumes, the only differences remaining lo-
calize in the above-mentioned crevice (Fig. 4 c, violet).
We attribute these differences to bound IpTx
 
a
 
-B:SA, and
hereafter we refer to them as such. The fact that these dif-
ferences appeared at the same threshold as the control and
experimental volumes is indicative that most of the recep-
tors had all four sites occupied. This finding is supported
by the results of Gurrola et al. (1999) who have reported
that 4 mol of IpTx
 
a
 
 bind per mole of tetrameric RyR1.
The locations of the bound IpTx
 
a
 
-B:SA agree with the
positions of the four significant differences seen in the 2D
analysis (compare Fig. 4 c, violet 3D masses, left panel,
and Fig. 3, c and d, which are in the same orientation).
Whereas 2D averages are performed using square projec-
tions only, most of the input data for 3D reconstruction
come from other views. Thus, agreement in the differences
detected by the 2D and 3D analyses is a further test of the
internal consistency of the results.
The attachment of IpTx
 
a
 
-B:SA (Fig. 4 c, violet regions) to
the RyR1 appears to occur near the base of the crevice (Fig.
5 a), indicating that IpTx
 
a
 
-B, the link between RyR1 and
SA, is probably located at this region of the difference map.
The apparent size of the surface-rendered difference be-
tween the experimental and control reconstructions ap-
pears to be smaller than SA’s dimensions. This discrep-
ancy likely results from a loss of signal at the distal regions
of the SA due to its mobility, and thus dilution of the sig-
nal through averaging. Similar effects have been seen in
reconstructions using antibodies as ligands (e.g., Yu et al.,
1998). Furthermore, analysis of the variance associated
with the 2D average of RyR1:IpTx
 
a
 
-B:SA shows locally
high variance of the mass attributed to SA in the distal re-
gion, which would be consistent with mobility of this pro-
tein (not shown).
Although IpTx
 
a
 
 has been shown to induce subconduc-
tance states in the RyR1 (Tripathy et al., 1998), our 3D re-
construction of the RyR1 containing bound IpTx
 
a
 
-B and
SA does not reveal any major conformational changes
such as were reported for ryanodine-modified RyR1 (Or-
lova et al., 1996). Perhaps minor differences exist, but they
are unappreciable at our current resolution.
 
Discussion
 
Allosteric Activation by IpTx
 
a
 
Binding of IpTx
 
a
 
 to the RyR1 induces the appearance of
Figure 3. (a) 2D average of 221 four-
fold symmetric particles corresponding
to RyR1 incubated with IpTxa-B and
SA. (b) 2D average of 215 particles
corresponding to the RyR1 control
sample. The arrowheads point to the
four symmetry-related locations where
there is extra mass in the presence of
IpTxa-B. (c) 2D difference map show-
ing the IpTxa-B:SA locations (in
white). (d) t test displaying statistically
significant regions of the difference
map at the 98% confidence level (in
white). 2D averages were filtered to
their limiting resolution (29 Å). Bar,
10 nm. 
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subconductance states of long lifetime. Our finding that
the IpTx
 
a
 
 binding locations are far (
 
,
 
11 nm) from the cen-
ter of the cytoplasmic side of the transmembrane region of
the channel supports an allosteric mechanism of action of
IpTx
 
a
 
 as opposed to a mechanism involving direct posi-
tioning of the toxin within the ion conducting channel
(both models have been discussed by Tripathy et al.
[1998]). IpTx
 
a
 
 is the third modulator ligand of RyR1 that
has been localized by cryo-microscopy and 3D reconstruc-
tion, and intriguingly, all three bind to sites on the cyto-
plasmic region of the receptor that are far from the trans-
membrane portion of RyR1. The other mapped ligands
are calmodulin, which binds at a site near that found here
for IpTx
 
a
 
,
 
 
 
and FK506-binding protein, which binds at the
periphery of the cytoplasmic region on the opposite side of
domain 3 from that of IpTx
 
a 
 
(Wagenknecht et al., 1997). It
seems possible that domain 3 plays a key role in the allo-
steric mechanism of channel modulation by these ligands,
perhaps by moving so as to affect the conformation of
the transmembrane assembly to which it appears to be
Figure 4. (a) Solid body representations of the 3D reconstruction of RyR1 incubated in the presence of IpTxa-B and SA. Resolution,
29 Å. (b) 3D reconstruction of RyR1 control incubated in the presence of SA. Resolution, 29 Å. (c) Control reconstruction (green) with
differences (violet) obtained by subtracting reconstruction in a and b superimposed. This map shows the locations of bound IpTxa-B:SA
(violet). The volumes are seen from the T tubule–facing side (left), SR-facing side (middle), and from the side (right) with the cytoplas-
mic moiety of the receptor on top, and the transmembrane assembly at the bottom. The numerals point to distinguishable domains as de-
scribed in Radermacher et al. (1994).The Journal of Cell Biology, Volume 146, 1999 498
connected by a bridge of density (Fig. 5 b, short dashed
line). IpTxa could also affect the transmembrane domain
through the other bridge of density indicated by the long
dashed line in Fig. 5 b, or through a concerted movement
of both of them.
Mimicry by the II-III Loop of the a1 Subunit of
the DHPR
Recently, convincing evidence has been reported in sup-
port of the hypothesis that IpTxa mimics the effects of
RyR1-activating peptides derived from the DHPR (Gur-
rola et al., 1999). Specifically, residues 681–687 (Arg-Lys-
Arg-Arg-Lys-Met-Ser), which lie in the cytoplasmic II-III
loop (residues 666–791; Tanabe et al., 1990) of the a1 sub-
unit of the DHPR, are crucial for the activating effects that
the isolated II-III loop and various derived subfragments
have on the RyR1 (Lu et al., 1994, 1995; El-Hayek et al.,
1995a; El-Hayek and Ikemoto, 1998). A similar cluster
of basic amino acids followed by a hydroxyl-containing
amino acid occurs at residues 19–26 of IpTxa (Lys-Lys-
Cys-Lys-Arg-Arg-Gly-Thr) and is essential for the effects
of IpTxa on RyR1 (Gurrola et al., 1999). Although the pre-
cise role of the II-III loop in E-C coupling seems to be
complex, including its relationship to other regions of the
DHPR or other components of the triad junction (El-
Hayek and Ikemoto, 1998; Leong and MacLennan, 1998b;
Nakai et al., 1998), the mimicry shown by IpTxa suggests
that the site of IpTxa binding on the 3D architecture of
RyR1 can potentially correspond to a DHPR interaction
site crucial for E-C coupling.
In this context, the 37–amino acid sequence Arg1076–
Asp1112 from RyR1 that interacts with the DHPR II-III
loop identified by Leong and MacLennan (1998a,b) would lo-
cate at the base of the crevice between domains 3 and 7/8.
To correlate further our results with the work implicat-
ing IpTxa as a DHPR mimic, we examined how the density
attributed to IpTxa-B:SA in our reconstruction (Fig. 4 c, vi-
olet) fits into the known quaternary arrangement of DHPRs
at the triad junction (Block et al., 1988). The distance be-
tween the centers of mass of neighboring IpTxa-B:SA is 15
nm, which would lie within the boundaries defined by the
morphologic units (DHPRs) comprising the tetrads seen
by freeze-fracture EM (for this comparison we project the
four IpTxa-B:SA per RyR1 and the four subunits of a tet-
rad into a plane normal to the axis of fourfold symmetry).
In the orthogonal direction (i.e., parallel to the fourfold
axis of the RyR1s), the differences attributed to IpTxa-B:
SA are ,5 nm from the T tubule–facing side of domain 4
of RyR1 (Fig. 4 c, side view). For the basic sequence of the
II-III loop to extend to this region would apparently re-
quire a fully extended conformation for the first 15 resi-
dues of the II-III loop that precede it (El-Hayek et al.,
1995a). Alternatively, a less extended configuration would
suffice if the interaction between RyR1 and DHPR in-
volves more interdigitation than supposed.
Regardless of the potential use of IpTxa as a tool to help
elucidate E-C coupling, it is important to emphasize that
IpTxa produces discrete functional effects on RyR1 that
ultimately lead to calcium release in isolated SR vesicles
(Gurrola et al., 1999) and in skinned muscle cells (Shift-
man et al., 1999). Thus, activation of the IpTxa binding do-
main identified here must lead to conformational changes
in RyR1 that shift channel conductance.
In conclusion, we have found by cryo-EM and 3D recon-
struction that IpTxa binds to RyR1 along the edges of the
cytoplasmic assembly, in a crevice between the clamp and
handle domains. We suggest that a subtle conformational
change mediates pore gating and toxin binding, and we
discuss the possibility that the toxin binding location rep-
resents one of the physiological activating sites of RyR1
during E-C coupling.
Figure 5. 3D reconstructions of the control RyR1 displayed in
different orientations to illustrate specific features. (a) Likely site
of attachment of IpTxa to RyR1. The difference map was dis-
played at a higher threshold (in violet) to determine the region of
higher rigidity. This region remains connected to the RyR1 struc-
ture at one location, suggesting that this is the attachment site.
(b) The dashed lines indicate bridges of mass connecting domain
3 and the transmembrane assembly. The asterisk indicates the
likely site of attachment of IpTxa.Samsó et al. Three-dimensional Location of IpTxa on the Ryanodine Receptor 499
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